Analytical Procedure Lifecycle Management / Revisions to ICH Q2 & the proposed Q14 This conference is part of PharmaLab 2019
Düsseldorf/Neuss, Germany
Course No 200032
Our Service
Costs
This training/webinar cannot be booked. To find alternative dates for this training/webinar or similar events please see the events list by topic.
For many training courses and webinars, there are also recordings you can order and watch any time. You can find these recordings in a list sorted by topic.
Or simply send us your inquiry by using the following contact form.
* also payable by credit card
If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org
Programme
Programme - 12 November 2019
Congress Keynote 12.11.2019: New ICH Q14 and ICH Q2 Revision – an industry view (Key Note Presentation at the Plenum)
New ICH Q14 and ICH Q2 Revision – an industry view (Keynote Presentation at the Plenum)
Dr Joachim Ermer, Sanofi-Aventis Deutschland Head of QC Lifecycle Management Frankfurt Chemistry
Introduction to ECA AQCG
Dr Christopher Burgess, Chairman of the ECA AQCG Board
Overview of USP, ICH revisions & APLM Guideline; Prerequisites and approaches
Dr Christopher Burgess, Chairman of the ECA AQCG Board
Introduction to ATP & TMU
Phil Borman, GSK
Data integrity over the Analytical Procedure Lifecycle
Bob McDowall, R.D. McDowall Limited
Stage 1: Procedure Design & Development
Margarita Sabater, Dako Denmark, an Agilent Technologies Company
Stage 1 in Practice
Phil Borman, GSK
Analytical Control Strategy Workshop
Dr Gerd Jilge, Boehringer Ingelheim
Margarita Sabater, Dako Denmark, an Agilent Technologies Company
Programme - 13 November 2019
Congress Keynote 13.11.2019: Laboratory Services - from Outsourcing to a strategic partnership (Key Note Presentation at the Plenum)
Laboratory Services - from Outsourcing to a strategic partnership (Key Note Presentation at the Plenum)
Dr Jürgen Balles, Dr Thomas Meindl and Ingo Grimm, Labor LS
Stage 2: Procedure Performance Qualification: Problems and issues?
Dr Gerd Jilge, Boehringer Ingelheim
Approaches to the transfer of Analytical Procedures
Ulla Bondegaard, Novo Nordisk
Stage 3: Procedure Performance Verification
Silviya Dimitrova, Teva
Experiences in the ongoing verification of Analytical Procedures
Ulla Bondegaard, Novo Nordisk
"What happens with Legacy Products?" Workshop
Silviya Dimitrova, Teva
Dr Christopher Burgess, Burgess Analytical Consultancy
GMP Conferences by Topics
- General Quality Assurance and GMP Compliance Topics
- Hygiene
- General Microbiology Topics
- Regulatory Affairs
- Development
- General Analytics Topics
- Good Distribution Practice
- Sterile Manufacturing
- Computer Validation
- General Qualification/Validation Topics
- General Engineering Topics
- APIs/Excipients
- GMP Basic Training Courses
- Medical Devices and Combination Products
- Packaging and Packaging Material
- Data Integrity
- Qualified Person (QP)
- GMP Auditing
- Documentation
- Cleaning Validation
- General IT Compliance Topics
- Impurities
- OOS / OOE / OOT
- Material Testing
- Validation of Analytical Methods
- Analytical Instrument Qualification
- Stability Testing
- Microbiological Testing
- Technology
- General Manufacturing Topics
- Solid Dosage Forms/Semi-Solid Dosage Forms
- Biotechnology/Blood/ATMP
- Herbal Drug Products/Cannabis/Radiopharmaceuticals
- Others